ArticleAmerican journal of men's health
The Clinical, Genetic, Psychosocial, and Care Landscape of X-Linked Dystonia-Parkinsonism in Filipino Men: A Scoping Review.
Article in American journal of men's health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundX-linked dystonia-parkinsonism (XDP) is a hereditary movement disorder predominantly affecting Filipino males from Panay Island ancestry. Existing research emphasizes molecular and motor aspects, neglecting diagnostic, therapeutic, and psychosocial impacts.ObjectivesTo map the literature on XDP in Filipino men, including its genetic basis, clinical features, diagnostic methods, treatment options, and psychosocial effects.MethodsWe conducted a systematic search following the Joanna Briggs Institute (JBI) methodology and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) principles.ResultsA total of 27 studies were included. Symptoms commenced from localized to widespread dystonia. Parkinsonism manifested within one to two years. Most examined patients exhibited the TAF1 genetic mutation, and diagnosis takes years. Deep-brain stimulation reduced dystonia severity. Pharmacological therapies produced some benefits. Qualitative analysis revealed stigma and identity loss, caregiver burden, financial hardship, and coping and resilience.ConclusionsXDP exhibits a rapid and severe growth trend; however, access to diagnostic tests, modern medicines, and supportive care remains unequal. To address these disparities, it is essential to improve access to genetic and clinical treatments and incorporate psychosocial support systems, including stigma reduction, caregiver assistance, and community networks, into a comprehensive care model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.